Everest Organics [EVERESTO] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Everest Organics Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Everest Organics Ltd. wins in 4 metrics, Sun Pharmaceutical Industries Ltd. wins in 15 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Everest Organics Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 52.29 36.73 Sun Pharmaceutical Industries Ltd.
Price-to-Book Ratio 3.71 5.15 Everest Organics Ltd.
Debt-to-Equity Ratio 68.11 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio -0.71 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 18.13 23.61 Everest Organics Ltd.
Profit Margin (TTM) 3.08% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 5.30% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 5.30% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity -1.84% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) -0.57% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-108.03M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -37.06% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 1.42 7.05 Everest Organics Ltd.
Enterprise Value $3.19B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 1.69 6.66 Everest Organics Ltd.
Gross Profit Margin (TTM) 38.71% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $197 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $5.29 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.43 0.11 Sun Pharmaceutical Industries Ltd.

Everest Organics Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

EVERESTO
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Everest Organics Ltd.6.20%-10.00%-11.08%-15.32%-43.80%-53.20%
Sun Pharmaceutical Industries Ltd.-0.47%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Everest Organics Ltd.-37.06%167.84%-27.25%931.92%6,868.83%6,868.83%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Everest Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricEVERESTOSUNPHARMA
Market Information
Market Cap i₹2.64B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,4823,903,142
90 Day Avg. Volume i9,1993,253,866
Last Close₹248.50₹1,780.10
52 Week Range₹197.00 - ₹536.40₹1,548.00 - ₹1,916.60
% from 52W High-53.67%-7.12%
All-Time High₹536.40 (Jan 02, 2026)₹1,960.35 (Sep 30, 2024)
% from All-Time High-53.67%-9.19%
Growth Metrics
Quarterly Revenue Growth0.02%0.14%
Quarterly Earnings Growth-0.69%0.16%
Financial Health
Profit Margin (TTM) i0.03%0.19%
Operating Margin (TTM) i0.05%0.26%
Return on Equity (TTM) i-0.02%0.15%
Debt to Equity (MRQ) i68.116.68
Cash & Liquidity
Book Value per Share (MRQ)₹74.65₹324.46
Cash per Share (MRQ)₹1.08₹115.87
Operating Cash Flow (TTM) i₹38.10M₹110.84B
Levered Free Cash Flow (TTM) i₹-12,903,000₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend i₹0.00₹16.50

Valuation & Enterprise Metrics Analysis: Everest Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricEVERESTO (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i52.2936.73
Forward P/E iN/A29.48
PEG Ratio i-0.713.59
Price to Sales (TTM) i1.427.05
Price to Book (MRQ) i3.715.15
Market Capitalization
Market Capitalization i₹2.64B₹3.88T
Enterprise Value i₹3.19B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i1.696.66
Enterprise to EBITDA i18.1323.61
Risk & Other Metrics
Beta i0.430.11
Book Value per Share (MRQ) i₹74.65₹324.46

Financial Statements Comparison: Everest Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEVERESTO (2025)SUNPHARMA (2025)
Revenue/Sales i1.59B520.41B
Cost of Goods Sold i985.43M121.98B
COGS % of Revenue i61.8%23.4%
Gross Profit i609.36M398.44B
Gross Margin i38.2%76.6%
Research & Development i8.29MN/A
Operating Income (EBIT) i23.83M125.81B
Operating Margin i1.5%24.2%
EBITDA i78.09M167.25B
EBITDA Margin i4.9%32.1%
Pre-Tax Income i-32.43M137.52B
Pre-Tax Income % of Revenue i-2.0%26.4%
Income Tax i-19.52M27.72B
Income Tax % of Revenue i-1.2%5.3%
Net Income (Profit) i-12.90M109.65B
Profit Margin i-0.8%21.1%

Balance Sheet & Liquidity Metrics

MetricEVERESTO (2025)SUNPHARMA (2025)
Cash & Equivalents i60.92M102.69B
Total Current Assets i1.48B526.24B
Total Current Assets % of Revenue i92.7%101.1%
Total Current Liabilities i1.40B181.94B
Total Current Liabilities % of Revenue i87.7%35.0%
Long-Term Debt i91.98M3.58B
Long-Term Debt % of Revenue i5.8%0.7%
Total Shareholders Equity i699.47M724.86B
Retained Earnings i312.18M578.62B
Retained Earnings % of Revenue i19.6%111.2%
Property, Plant & Equipment i483.39M100.36B

Cash Flow Statement Comparison

MetricEVERESTO (2025)SUNPHARMA (2025)
Operating Cash Flow i38.10M110.84B
Operating Cash Flow % of Revenue i2.4%21.3%
Capital Expenditures i-35.77M-20.68B
Free Cash Flow i-108.03M119.44B
FCF Margin i-6.8%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricEVERESTOSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.71M2.40B
Float Shares i978,9581.07B
% Held by Insiders i76.90%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i23.10%15.69%

Dividend Analysis & Yield Comparison: Everest Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricEVERESTOSUNPHARMA
Last 12-Month Dividend i₹0.00₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend i₹0.17₹17.33
3-Year Avg Dividend Yield i0.35%0.51%
3-Year Total Dividends i₹0.50₹52.00
Ex-Dividend DateSep 15, 2022Feb 05, 2026